Singulus Technologies AG : The trend should regain control
Entry price | Target | Stop-loss | Potential |
---|
€9.45 |
€12.11 |
€9 |
+28.15% |
---|
Shares in SINGULUS TECHNOLOGIES AG do not show any sign of a slowdown in the ascending dynamic. Investors could bet on a continuation of the underlying trend.
Summary● The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
● The company has poor fundamentals for a short-term investment strategy.
Strengths● Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
● The company is in a robust financial situation considering its net cash and margin position.
● The stock, which is currently worth 2017 to 0.42 times its sales, is clearly overvalued in comparison with peers.
● The tendency within the weekly time frame is positive above the technical support level at 5.87 EUR
Weaknesses● The firm trades with high earnings multiples: 24.87 times its 2017 earnings per share.
● The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
● For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.